• Markets
  • icon
  • Companies
NTI · ASX

Neurotech International Ltd. (ASX:NTI)

AU$0.1

 0.0 (0.0%)
ASX:Live
12/04/2024 04:10:59 PM
HALO Price Momentum HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

NTI Overview

NTI Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About NTI

Telephone

N/A

Address

Description

N/A

NTI Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

0%

1 month

6.06%

YTD

38.16%

1 year

98.11%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

NTI Announcements

Latest Announcements

Date Announcements

10 April 24

Last Patient Completes Treatment in NTIASD2 Clinical Trial

×

Last Patient Completes Treatment in NTIASD2 Clinical Trial

10 April 24

Strategic Partnership with Fenix Innovation Group

×

Strategic Partnership with Fenix Innovation Group

10 April 24

Proposed issue of securities - NTI

×

Proposed issue of securities - NTI

27 March 24

Change in substantial holding

×

Change in substantial holding

21 March 24

Neurotech Presentation at NWR Virtual Healthcare Conference

×

Neurotech Presentation at NWR Virtual Healthcare Conference

21 March 24

Appointment of Joint Company Secretary

×

Appointment of Joint Company Secretary

19 March 24

Neurotech to present at NWR Virtual Healthcare Conference

×

Neurotech to present at NWR Virtual Healthcare Conference

15 March 24

Application for quotation of securities - NTI

×

Application for quotation of securities - NTI

15 March 24

Notification regarding unquoted securities - NTI

×

Notification regarding unquoted securities - NTI

15 March 24

Secondary Trading Notice

×

Secondary Trading Notice

13 March 24

Rett Syndrome Patients to Receive NTI164 for 52 Weeks

×

Rett Syndrome Patients to Receive NTI164 for 52 Weeks

13 March 24

NTI to Present at Spark Plus Conference in Singapore

×

NTI to Present at Spark Plus Conference in Singapore

12 March 24

Notification of cessation of securities - NTI

×

Notification of cessation of securities - NTI

11 March 24

Secondary Trading Notice

×

Secondary Trading Notice

08 March 24

Application for quotation of securities - NTI

×

Application for quotation of securities - NTI

08 March 24

Notification regarding unquoted securities - NTI

×

Notification regarding unquoted securities - NTI

27 February 24

Appendix 4D and Half Year Accounts

×

Appendix 4D and Half Year Accounts

27 February 24

Initial ESG Report

×

Initial ESG Report

21 February 24

PANDAS/PANS Patients Show Continued Clinical Improvement

×

PANDAS/PANS Patients Show Continued Clinical Improvement

21 February 24

Investor Presentation

×

Investor Presentation

14 February 24

Application for quotation of securities - NTI

×

Application for quotation of securities - NTI

14 February 24

Notification regarding unquoted securities - NTI

×

Notification regarding unquoted securities - NTI

14 February 24

Secondary Trading Notice

×

Secondary Trading Notice

13 February 24

Neurotech Receives Additional HREC Approval in Autism

×

Neurotech Receives Additional HREC Approval in Autism

07 February 24

ASD Phase I/II Patients Exceed Treatment Beyond 90 Weeks

×

ASD Phase I/II Patients Exceed Treatment Beyond 90 Weeks

NTI Fundamentals

Per Share Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.02 -0.00 -0.01 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.02 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock -36.0 68.2 -104.2 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.00 -0.00 -0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 32.8 -22.6 -68.4 Lock Lock Lock
     Yield % Lock Lock Lock Lock -8.9 -6.1 -19.8 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.01 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 284.5 -63.0 121.2 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 493 697 799 Lock Lock Lock
Basic m Lock Lock Lock Lock 493 697 799 Lock Lock Lock

Financial Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 166.5 -81.4 -84.4 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 7 3 9 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock 56.3 -124.2 100.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -115.8 -1,398.8 70.7 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 216 1,499 29 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -7 -4 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -526.3 47.4 -130.0 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,611.7 -10,243.8 -151,313.1 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -7 -4 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock -486.3 47.3 -130.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,611.7 -10,245.3 -151,342.3 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -7 -4 -9 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -7 -3 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -333.7 54.8 -131.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,604.6 -8,787.4 -130,759.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -2 -3 -6 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 7 0 9 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -2 -3 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -239.3 -27.7 -113.5 Lock Lock Lock
     Margin % Lock Lock Lock Lock -11.2 -77.3 -1,060.1 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 5 2 5 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 5 2 5 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -5 -2 -5 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 4 1 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 4 1 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 697.5 -63.0 177.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -148.4 -166.2 -146.8 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -192.4 -235.1 -196.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -455.5 -148.2 -334.5 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -462.2 -127.1 -289.0 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -144.1 -111.7 -234.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -4,356.5 -2,863.0 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.6 0.5 0.6 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -125.0 -132.5 -126.9 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 14.3 3.4 3.9 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 14.3 3.4 3.9 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 96.4 93.8 94.7 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -663.0 -498.4 -469.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 2.0 0.3 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A 159.3 0.2 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 157.2 1,359.2 21,632.8 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -3,604.6 -10,275.4 -150,704.3 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -148.4 -194.3 -169.2 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -148.4 -166.2 -146.8 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.3 1.4 1.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -192.4 -235.1 -196.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -192.4 -235.1 -196.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A 2.3 1,567.9 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 179.0 1,155.9 10,934.8 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 179.0 1,158.2 12,502.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 405.5 265.3 140,384.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -226.5 892.9 -127,881.9 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NTI Shortsell

Frequently Asked Questions

The current share price of Neurotech International Ltd. (NTI:ASX) is AU$0.1.
The 52-week high share price for Neurotech International Ltd. (NTI:ASX) is AU$0.00.
The 52-week low share price for Neurotech International Ltd. (NTI:ASX)? is AU$0.00.
Neurotech International Ltd. (NTI:ASX) does not pay a dividend.
Neurotech International Ltd. (NTI:ASX) does not pay a dividend.
Neurotech International Ltd. (NTI:ASX) does not offer franking credits.
Neurotech International Ltd. (NTI:ASX) is classified in the Healthcare.